From: Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review
Characteristic | No. | % of 139 articles |
---|---|---|
Type of article | ||
Original research | ||
Randomized-controlled trial | 52 | 37.4 % |
Before-after study | 8 | 5.8 % |
Nonrandomized controlled trial | 6 | 4.3 % |
Systematic review/meta-analysis | 3 | 2.2 % |
Prospective cohort study | 2 | 1.4 % |
Non-comparative study | 2 | 1.4 % |
Retrospective cohort study | 1 | 0.7 % |
Non-original research | ||
Narrative review | 58 | 41.7 % |
Guideline | 7 | 5.0 % |
Country of origin | ||
United States | 38 | 27.3 % |
United Kingdom | 33 | 23.7 % |
Europe | 24 | 17.3 % |
Canada | 20 | 14.4 % |
Australia | 13 | 9.4 % |
Asia | 2 | 1.4 % |
Other | 9 | 6.5 % |
Year of publication | ||
<1985 | 4 | 2.9 % |
1985–1994 | 50 | 36.0 % |
1995–2004 | 40 | 28.8 % |
2005–2015 | 45 | 32.4 % |
Primary medical condition | ||
Mixed | 73 | 52.5 % |
Anxiety disorders | 27 | 19.4 % |
Insomnia | 23 | 16.5 % |
Panic disorders | 16 | 11.5 % |